Poland, Aug. 1 -- Poland based Urtica Sp. z o.o. has secured contract from Uniwersytet Medyczny w Lodzi for Pharmaceutical Products-Successive Delivery of Medicinal Products (Ruksolitinib) for the implementation of non-commercial clinical trial "Single-Car interventional stud Like/stathway ". The value of the contract is worth 44042635 PLN.
Published by HT Digital Content Services with permission from Pivotal Sources....